Activation of mTORC2 by association with the ribosome

Cell

Volumn 144, Issue 5, 2011, Pages 757-768

  Zinzalla, Vittoria ^a   Stracka, Daniele ^a   Oppliger, Wolfgang ^a   Hall, Michael N ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITOL 3 KINASE;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; GENETIC SCREENING; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; RIBOSOME; SIGNAL TRANSDUCTION; UPREGULATION; YEAST;

MAMMALIA;

EID: 79952293503     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2011.02.014     Document Type: Article

References (75)

1. S. Aronova, K. Wedaman, P.A. Aronov, K. Fontes, K. Ramos, B.D. Hammock, and T. Powers Regulation of ceramide biosynthesis by TOR complex 2 Cell Metab. 7 2008 148 158 (Pubitemid 351168557)
2. J. Avruch, X. Long, S. Ortiz-Vega, J. Rapley, A. Papageorgiou, and N. Dai Amino acid regulation of TOR complex 1 Am. J. Physiol. Endocrinol. Metab. 296 2009 E592 E602
3. M. Barna, A. Pusic, O. Zollo, M. Costa, N. Kondrashov, E. Rego, P.H. Rao, and D. Ruggero Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency Nature 456 2008 971 975
4. T. Beeler, D. Bacikova, K. Gable, L. Hopkins, C. Johnson, H. Slife, and T. Dunn The Saccharomyces cerevisiae TSC10/YBR265w gene encoding 3-ketosphinganine reductase is identified in a screen for temperature-sensitive suppressors of the Ca2+-sensitive csg2Delta mutant J. Biol. Chem. 273 1998 30688 30694 (Pubitemid 28545550)
5. M. Boyce, K.F. Bryant, C. Jousse, K. Long, H.P. Harding, D. Scheuner, R.J. Kaufman, D. Ma, D.M. Coen, D. Ron, and J. Yuan A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress Science 307 2005 935 939 (Pubitemid 40229232)
6. D.P. Brazil, Z.Z. Yang, and B.A. Hemmings Advances in protein kinase B signalling: AKTion on multiple fronts Trends Biochem. Sci. 29 2004 233 242 (Pubitemid 38591317)
7. A. Casamayor, P.D. Torrance, T. Kobayashi, J. Thorner, and D.R. Alessi Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast Curr. Biol. 9 1999 186 197 (Pubitemid 29120382)
8. M. Ceci, C. Gaviraghi, C. Gorrini, L.A. Sala, N. Offenhäuser, P.C. Marchisio, and S. Biffo Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly Nature 426 2003 579 584 (Pubitemid 37522646)
9. U. Certa, M. Seiler, E. Padovan, and G.C. Spagnoli High density oligonucleotide array analysis of interferon- alpha2a sensitivity and transcriptional response in melanoma cells Br. J. Cancer 85 2001 107 114 (Pubitemid 32695725)
10. A. Chiocchetti, L. Gibello, A. Carando, A. Aspesi, P. Secco, E. Garelli, F. Loreni, M. Angelini, A. Biava, and N. Dahl Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein Haematologica 90 2005 1453 1462 (Pubitemid 41658757)
11. M. Cnop, L. Ladriere, P. Hekerman, F. Ortis, A.K. Cardozo, Z. Dogusan, D. Flamez, M. Boyce, J. Yuan, and D.L. Eizirik Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis J. Biol. Chem. 282 2007 3989 3997 (Pubitemid 47084497)
12. N. Cybulski, and M.N. Hall TOR complex 2: a signaling pathway of its own Trends Biochem. Sci. 34 2009 620 627
13. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241 (Pubitemid 27456390)
14. M. Deschodt-Lanckman, Y. Vanneste, B. Loir, A. Michel, A. Libert, G. Ghanem, and F. Lejeune Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture Int. J. Cancer 46 1990 1124 1130
15. R.M. Drenan, X. Liu, P.G. Bertram, and X.F. Zheng FKBP12-rapamycin- associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus J. Biol. Chem. 279 2004 772 778 (Pubitemid 38044883)
16. V. Facchinetti, W. Ouyang, H. Wei, N. Soto, A. Lazorchak, C. Gould, C. Lowry, A.C. Newton, Y. Mao, and R.Q. Miao The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C EMBO J. 27 2008 1932 1943
17. M.E. Feldman, B. Apsel, A. Uotila, R. Loewith, Z.A. Knight, D. Ruggero, and K.M. Shokat Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 PLoS Biol. 7 2009 e38
18. M.A. Frias, C.C. Thoreen, J.D. Jaffe, W. Schroder, T. Sculley, S.A. Carr, and D.M. Sabatini mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s Curr. Biol. 16 2006 1865 1870 (Pubitemid 44354144)
19. J.M. García-Martínez, and D.R. Alessi mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) Biochem. J. 416 2008 375 385
20. N. Gervois, Y. Guilloux, E. Diez, and F. Jotereau Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions J. Exp. Med. 183 1996 2403 2407 (Pubitemid 26158935)
21. S. Grosso, V. Volta, L.A. Sala, M. Vietri, P.C. Marchisio, D. Ron, and S. Biffo PKCbetaII modulates translation independently from mTOR and through RACK1 Biochem. J. 415 2008 77 85
22. S. Grosso, V. Volta, M. Vietri, C. Gorrini, P.C. Marchisio, and S. Biffo Eukaryotic ribosomes host PKC activity Biochem. Biophys. Res. Commun. 376 2008 65 69
23. D.A. Guertin, D.M. Stevens, M. Saitoh, S. Kinkel, K. Crosby, J.H. Sheen, D.J. Mullholland, M.A. Magnuson, H. Wu, and D.M. Sabatini mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice Cancer Cell 15 2009 148 159
24. P. Gulhati, Q. Cai, J. Li, J. Liu, P.G. Rychahou, S. Qiu, E.Y. Lee, S.R. Silva, K.A. Bowen, T. Gao, and B.M. Evers Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer Clin. Cancer Res. 15 2009 7207 7216
25. K. Hara, Y. Maruki, X. Long, K. Yoshino, N. Oshiro, S. Hidayat, C. Tokunaga, J. Avruch, and K. Yonezawa Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action Cell 110 2002 177 189 (Pubitemid 34876546)
26. H.N. He, X. Wang, X.L. Zheng, H. Sun, X.W. Shi, Y.J. Zhong, B. Huang, L. Yang, J.K. Li, and L.C. Liao Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity Cancer Lett. 295 2010 38 43
27. S.B. Helliwell, I. Howald, N. Barbet, and M.N. Hall TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae Genetics 148 1998 99 112 (Pubitemid 28063479)
28. R.C. Hresko, and M. Mueckler mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes J. Biol. Chem. 280 2005 40406 40416 (Pubitemid 41780527)
29. A.C. Hsieh, M. Costa, O. Zollo, C. Davis, M.E. Feldman, J.R. Testa, O. Meyuhas, K.M. Shokat, and D. Ruggero Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E Cancer Cell 17 2010 249 261
30. R.A. Idol, S. Robledo, H.Y. Du, D.L. Crimmins, D.B. Wilson, J.H. Ladenson, M. Bessler, and P.J. Mason Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production Blood Cells Mol. Dis. 39 2007 35 43 (Pubitemid 46754918)
31. T. Ikenoue, K. Inoki, Q. Yang, X. Zhou, and K.L. Guan Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling EMBO J. 27 2008 1919 1931
32. E. Jacinto, V. Facchinetti, D. Liu, N. Soto, S. Wei, S.Y. Jung, Q. Huang, J. Qin, and B. Su SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 127 2006 125 137 (Pubitemid 44466632)
33. E. Jacinto, R. Loewith, A. Schmidt, S. Lin, M.A. Rüegg, A. Hall, and M.N. Hall Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive Nat. Cell Biol. 6 2004 1122 1128 (Pubitemid 39468014)
34. E. Jacinto, and A. Lorberg TOR regulation of AGC kinases in yeast and mammals Biochem. J. 410 2008 19 37 (Pubitemid 351300322)
35. Y. Kamada, Y. Fujioka, N.N. Suzuki, F. Inagaki, S. Wullschleger, R. Loewith, M.N. Hall, and Y. Ohsumi Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization Mol. Cell. Biol. 25 2005 7239 7248 (Pubitemid 41105919)
36. A.H. Kim, G. Khursigara, X. Sun, T.F. Franke, and M.V. Chao Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1 Mol. Cell. Biol. 21 2001 893 901 (Pubitemid 32104737)
37. D.H. Kim, D.D. Sarbassov, S.M. Ali, J.E. King, R.R. Latek, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2002 163 175 (Pubitemid 34876545)
38. S. Komili, N.G. Farny, F.P. Roth, and P.A. Silver Functional specificity among ribosomal proteins regulates gene expression Cell 131 2007 557 571 (Pubitemid 350007691)
39. M. Laplante, and D.M. Sabatini mTOR signaling at a glance J. Cell Sci. 122 2009 3589 3594
40. M.S. Lindström Emerging functions of ribosomal proteins in gene-specific transcription and translation Biochem. Biophys. Res. Commun. 379 2009 167 170
41. X. Liu, and X.F. Zheng Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin Mol. Biol. Cell 18 2007 1073 1082 (Pubitemid 46399510)
42. R. Loewith, E. Jacinto, S. Wullschleger, A. Lorberg, J.L. Crespo, D. Bonenfant, W. Oppliger, P. Jenoe, and M.N. Hall Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control Mol. Cell 10 2002 457 468 (Pubitemid 35284167)
43. S.V. Madhunapantula, and G.P. Robertson The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma Pigment Cell Melanoma Res. 22 2009 400 419
44. B.D. Manning, and L.C. Cantley Rheb fills a GAP between TSC and TOR Trends Biochem. Sci. 28 2003 573 576 (Pubitemid 38352801)
45. J. Masri, A. Bernath, J. Martin, O.D. Jo, R. Vartanian, A. Funk, and J. Gera mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor Cancer Res. 67 2007 11712 11720
46. J.M. Mulet, D.E. Martin, R. Loewith, and M.N. Hall Mutual antagonism of target of rapamycin and calcineurin signaling J. Biol. Chem. 281 2006 33000 33007 (Pubitemid 46043258)
47. W.J. Oh, C.C. Wu, S.J. Kim, V. Facchinetti, L.A. Julien, M. Finlan, P.P. Roux, B. Su, and E. Jacinto mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide EMBO J. 29 2010 3939 3951
48. L.R. Pearce, X. Huang, J. Boudeau, R. Pawłowski, S. Wullschleger, M. Deak, A.F. Ibrahim, R. Gourlay, M.A. Magnuson, and D.R. Alessi Identification of Protor as a novel Rictor-binding component of mTOR complex-2 Biochem. J. 405 2007 513 522 (Pubitemid 47172049)
49. G.P. Robertson Functional and therapeutic significance of Akt deregulation in malignant melanoma Cancer Metastasis Rev. 24 2005 273 285 (Pubitemid 40922799)
50. D. Ruggero The role of Myc-induced protein synthesis in cancer Cancer Res. 69 2009 8839 8843
51. D. Ruggero, and P.P. Pandolfi Does the ribosome translate cancer? Nat. Rev. Cancer 3 2003 179 192 (Pubitemid 37328870)
52. D.D. Sarbassov, S.M. Ali, D.H. Kim, D.A. Guertin, R.R. Latek, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr. Biol. 14 2004 1296 1302 (Pubitemid 38991819)
53. D.D. Sarbassov, D.A. Guertin, S.M. Ali, and D.M. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 2005 1098 1101 (Pubitemid 40262113)
54. D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 22 2006 159 168
55. A. Schmidt, M. Bickle, T. Beck, and M.N. Hall The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2 Cell 88 1997 531 542 (Pubitemid 27154418)
56. W.A. Schroder, M. Buck, N. Cloonan, J.F. Hancock, A. Suhrbier, T. Sculley, and G. Bushell Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling Cell. Signal. 19 2007 1279 1289 (Pubitemid 46561564)
57. R.M. Seiser, and C.V. Nicchitta The fate of membrane-bound ribosomes following the termination of protein synthesis J. Biol. Chem. 275 2000 33820 33827
58. N. Sonenberg, and A.G. Hinnebusch Regulation of translation initiation in eukaryotes: mechanisms and biological targets Cell 136 2009 731 745
59. A. Soulard, A. Cohen, and M.N. Hall TOR signaling in invertebrates Curr. Opin. Cell Biol. 21 2009 825 836
60. C.A. Sparks, and D.A. Guertin Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy Oncogene 29 2010 3733 3744
61. J.M. Stahl, M. Cheung, A. Sharma, N.R. Trivedi, S. Shanmugam, and G.P. Robertson Loss of PTEN promotes tumor development in malignant melanoma Cancer Res. 63 2003 2881 2890 (Pubitemid 36667160)
62. J.M. Stahl, A. Sharma, M. Cheung, M. Zimmerman, J.Q. Cheng, M.W. Bosenberg, M. Kester, L. Sandirasegarane, and G.P. Robertson Deregulated Akt3 activity promotes development of malignant melanoma Cancer Res. 64 2004 7002 7010 (Pubitemid 39331010)
63. T.W. Sturgill, A. Cohen, M. Diefenbacher, M. Trautwein, D.E. Martin, and M.N. Hall TOR1 and TOR2 have distinct locations in live cells Eukaryot. Cell 7 2008 1819 1830
64. K. Thedieck, P. Polak, M.L. Kim, K.D. Molle, A. Cohen, P. Jenö, C. Arrieumerlou, and M.N. Hall PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis PLoS ONE 2 2007 e1217
65. X. Wang, K.D. McCullough, T.F. Franke, and N.J. Holbrook Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival J. Biol. Chem. 275 2000 14624 14631 (Pubitemid 30339753)
66. J.R. Warner, and K.B. McIntosh How common are extraribosomal functions of ribosomal proteins? Mol. Cell 34 2009 3 11
67. S. Wullschleger, R. Loewith, W. Oppliger, and M.N. Hall Molecular organization of target of rapamycin complex 2 J. Biol. Chem. 280 2005 30697 30704 (Pubitemid 41291798)
68. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484 (Pubitemid 43199434)
69. Q. Yang, and K.L. Guan Expanding mTOR signaling Cell Res. 17 2007 666 681 (Pubitemid 47255937)
70. Q. Yang, K. Inoki, T. Ikenoue, and K.L. Guan Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity Genes Dev. 20 2006 2820 2832 (Pubitemid 44771744)
71. N.I. Zanchin, P. Roberts, A. DeSilva, F. Sherman, and D.S. Goldfarb Saccharomyces cerevisiae Nip7p is required for efficient 60S ribosome subunit biogenesis Mol. Cell. Biol. 17 1997 5001 5015 (Pubitemid 27357599)
72. Helliwell, S.B.; Howald, I.; Barbet, N.; Hall, M.N. (1998). TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae. Genetics 148, 99-112. (Pubitemid 28063479)
73. Kamada, Y.; Fujioka, Y.; Suzuki, N.N.; Inagaki, F.; Wullschleger, S.; Loewith, R.; Hall, M.N.; Ohsumi, Y. (2005). Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol. Cell. Biol. 25, 7239-7248. (Pubitemid 41105919)
74. Thedieck, K.; Polak, P.; Kim, M.L.; Molle, K.D.; Cohen, A.; Jenö, P.; Arrieumerlou, C.; Hall, M.N. (2007). PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE 2, e1217.
75. Yang, Q.; Inoki, K.; Ikenoue, T.; Guan, K.L. (2006). Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820-2832. (Pubitemid 44771744)